Children ages 18 months to 48 months with an autism diagnosis, developmental delays, or a suspicion of autism are eligible.
CNY BUSINESS JOURNAL
HEALTH NEWS DIGEST
We develop solutions for important global health issues
Quadrant Biosciences is a molecular diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary advancements in the early detection of autism spectrum disorder, Parkinson’s disease and mTBI, through the application of the Clarifi® Dx molecular diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions.
Additionally, we are involved in three significant, complementary COVID-19 projects to aid in the detection of COVID-19 in individuals and communities across the U.S.